Skip to main content

Day: February 13, 2026

Kalmar’s financial statements review January–December 2025: Continued successful performance in 2025 with record order intake and solid sales growth in the fourth quarter

KALMAR CORPORATION, STOCK EXCHANGE RELEASE, 13 FEBRUARY 2026, AT 9.00 AM (EET)  Kalmar’s financial statements review January–December 2025: Continued successful performance in 2025 with record order intake and solid sales growth in the fourth quarterOrders received increased to a record of EUR 511 (486) million boosted by a few, sizeable equipment orders in the quarter Strong sales growth by 11 percent to EUR 487 (440) million Demand remained overall stable despite market uncertainty and trade tensions Comparable operating profit improved to EUR 60.5 (53.1) million, and was 12.4 (12.1) percentage of sales Approximately EUR 34 million of annualised gross efficiency improvements have been secured with the Driving Excellence initiative Operating cash flow increased 76 percent to MEUR 112.8 (64.2), positively impacted by inventory...

Continue reading

Hofseth BioCare ASA: FOURTH QUARTER 2025 FINANCIAL REPORT

HBC recorded total operating revenues of NOK 72.2 million in the fourth quarter of 2025, compared to NOK 64.9 million in the same period last year. Net operating revenues were NOK 71.1 million, up from NOK 64.9 million in Q4 2024. Full year 2025, total operating revenues amounted to NOK 256.3 million (265.5). Total operating revenue in 2024 included NOK 8.1 million of gain on sale of assets. EBITDA for the quarter was negative NOK 26.5 million, compared to negative NOK 26.1 million in Q4 2024. For full year 2025, EBITDA was negative NOK 72.9 million (-65.3). The Operational EBITDA* amounted to negative NOK 19.7 million (negative NOK 15.6 million in Q4 2024), excluding non-recurring and strategic development costs such as clinical trials and R&D expenses, and Berkåk project costs. For full year 2025, Operational EBITDA* was negative...

Continue reading

Norsk Hydro: Integrated Annual Report 2025: Increasing resilience to reach 2030 ambitions

2025 was another year marked by geopolitical instability. Hydro’s geographic diversification and integrated value chain strengthens the resilience in navigating these challenges. Throughout 2025, Hydro implemented measures to increase agility and accelerate growth to achieve the strategic goals for 2030.   Aluminium is classified as a critical raw material by EU, the U.S., and NATO, and Hydro’s low-carbon aluminium is therefore well positioned to play a key role in the green transition and the growing need for critical materials in the years ahead.   “We know that what we produce, where we produce it and how we produce it is more important than ever,” says Eivind Kallevik, President and CEO of Hydro, in his Letter to Stakeholders in the Integrated Annual Report 2025.  Adjusted EBITDA for 2025 was NOK 28.9 billion, up from NOK 26,3 billion in...

Continue reading

Year-end Report – January-December 2025

STOCKHOLM – 13 February 2025. KDventures AB (Nasdaq Stockholm: KDV) today publishes its Year-end Report January-December 2025. The full report is available on the Company’s website. “A stronger financial position under a new flag means we are well-positioned to continue supporting our portfolio companies in their efforts to develop new treatments in areas with substantial medical need”, says Viktor Drvota, CEO, KDventures. Significant events during the fourth quarterThe portfolio company Dilafor was granted a patent in the US, protecting its drug candidate tafoxiparin for its main target indication, priming of labor. The patent will serve as a key asset as Dilafor advances into phase 3 clinical development of tafoxiparin (October 2025). The portfolio company PharmNovo received approval from the Spanish regulatory authorities to...

Continue reading

Signify starts share repurchase program of up to 725,000 shares to cover performance share plans

Press Release February 13, 2026 Signify starts share repurchase program of up to 725,000 shares to cover performanceshare plans Eindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced the start of a program to repurchase up to 725,000 of its own shares. Signify will use the shares to cover obligations arising from its long-term incentive performance share plan and other employee share plans. The program will begin on February 13, 2026, and is expected to be completed by end April 2026. At the current share price, the 725,000 shares represent a total value of approximately EUR 14.5 million and 0.6% of the company’s issued share capital. Signify will hold the repurchased shares in treasury until share awards are vested. The program will be executed by an intermediary to allow for share repurchases...

Continue reading

Proposals by Huhtamäki Oyj’s Board of Directors to the Annual General Meeting of Shareholders

HUHTAMÄKI OYJ STOCK EXCHANGE RELEASE 13.2.2026 AT 8:45 (EET) Proposals by Huhtamäki Oyj’s Board of Directors to the Annual General Meeting of Shareholders The Annual General Meeting of Shareholders of Huhtamäki Oyj (the “Company”) (the “AGM”) will be held on Wednesday, April 29, 2026, at 11:00 (EEST), at Scandic Marina Congress Center, Katajanokanlaituri 6, 00160 Helsinki, Finland. The notice to convene the AGM is planned to be published on the Company’s website (www.huhtamaki.com) on March 30, 2026. The notice will include more detailed information on the participation and voting at the AGM. The proposals by the Shareholders’ Nomination Board to the AGM regarding the composition and remuneration of the Board of Directors were published on a separate stock exchange release on January 16, 2026. The proposals of the...

Continue reading

Sumitomo Forestry Announces Strategic Combination with Tri Pointe Homes to Create a Leading U.S. Homebuilder

Supports expansion of affordable U.S. housing supply in addition to accelerating growth of Tri Pointe Homes’ high-quality homebuilding operations and providing U.S. homebuyers with a broader array of housing options  Deepens Sumitomo Forestry’s U.S. investment with addition of Tri Pointe Homes’ more than 150 active communities and presence across 13 high-growth states Tri Pointe Homes stockholders to receive US$47.00 per share in all-cash transaction valued at approximately US$4.5 billion Represents approximately 29% premium to February 12 closing stock price, 42% premium to 90-day VWAP and exceeds all-time high closing stock price TOKYO and INCLINE VILLAGE, Nev., Feb. 13, 2026 (GLOBE NEWSWIRE) — Sumitomo Forestry Co., Ltd. (“Sumitomo Forestry”) (TSE: 1911) and Tri Pointe Homes, Inc. (“Tri Pointe Homes”) (NYSE: TPH), two companies...

Continue reading

Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025

Tokyo, Japan and Cambridge, UK, 13 February 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the fourth quarter and 12 months ended 31 December 2025. The full report can be viewed here. Christopher Cargill, President and CEO of Nxera Pharma, commented: “2025 was a year of disciplined execution and strategic progress for Nxera, as we continued to build a more focused, resilient and scalable biopharmaceutical business with a growing commercial footprint in Japan and a maturing pipeline. “In doing so, we further strengthened our commercial foundations in Japan and the broader APAC region, with PIVLAZ® for the prevention of cerebral vasospasm after aneurysmal subarachnoid haemorrhage firmly established as the standard of care in Japan. We...

Continue reading

Huhtamäki Oyj’s Results January 1–December 31, 2025: Solid performance despite adverse currency impacts

HUHTAMÄKI OYJ FINANCIAL STATEMENT RELEASE 13.2.2026 AT 8:30 EET Huhtamäki Oyj’s Results January 1–December 31, 2025: Solid performance despite adverse currency impacts Q4 2025 in briefNet sales decreased 7% to EUR 980.5 million (EUR 1,058.7 million) Comparable net sales growth at Group level was -2% Reported EBIT was EUR 89.0 million (EUR 95.0 million); adjusted EBIT was EUR 103.2 million (EUR 110.3 million) including an adverse currency impact of EUR 4.3 million Reported EPS was EUR 0.53 (EUR 0.61); adjusted EPS was EUR 0.65 (EUR 0.68) The impact of currency movements on the Group’s net sales was EUR -58.9 million and EUR -4.3 million on EBITQ1-Q4 2025 in briefNet sales decreased 4% to EUR 3,960.2 million (EUR 4,126.3 million) Comparable net sales growth at Group level was -1% Reported EBIT was EUR 320.5 million (EUR 372.3 million);...

Continue reading

Aedifica NV/SA: 2025 annual results

Please find below a press release from Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding its 2025 annual results. Aedifica’s Exchange Offer on all Cofinimmo shares is now openCofinimmo shareholders are offered 1.185 new Aedifica shares for each share they tender The Initial Acceptance Period will close on 2 March 2026 (16:00 CET) Results of the Initial Acceptance Period are expected to be announced on 6 March, with settlement scheduled on 13 MarchRobust operational performance driving strong results above budgetEPRA Earnings* amounted to €244.8 million (+4% compared to 31 Dec. 2024) or €5.15/share Rental income increased to €361.0 million (+7% compared to 31 Dec. 2024) 2.7% increase in rental income on a like-for-like basis* over the year Weighted average...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.